Cannabidiol Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as JAZZ PHARMS RES. It is marketed under 1 brand name, including EPIDIOLEX. Available in 1 different strength, such as 100MG/ML, and administered through 1 route including SOLUTION;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"76178","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US9956186B2","cleaned_patent_number":"9956186","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-05-01","legal_status":"Granted"} US9956186B2 01 May, 2018 Granted 17 Jun, 2035
{"application_id":"76244","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10111840B2","cleaned_patent_number":"10111840","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-10-30","legal_status":"Granted"} US10111840B2 30 Oct, 2018 Granted 17 Jun, 2035
{"application_id":"76245","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10137095B2","cleaned_patent_number":"10137095","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-11-27","legal_status":"Granted"} US10137095B2 27 Nov, 2018 Granted 17 Jun, 2035
{"application_id":"76212","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US10603288B2","cleaned_patent_number":"10603288","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2020-03-31","legal_status":"Granted"} US10603288B2 31 Mar, 2020 Granted 17 Jun, 2035
{"application_id":"76269","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"b82c1e1eb00840fb8fd3","publication_number":"US10709671B2","cleaned_patent_number":"10709671","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2020-07-14","legal_status":"Granted"} US10709671B2 14 Jul, 2020 Granted 17 Jun, 2035
{"application_id":"76246","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10709673B2","cleaned_patent_number":"10709673","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2020-07-14","legal_status":"Granted"} US10709673B2 Formulation 14 Jul, 2020 Granted 17 Jun, 2035
{"application_id":"76247","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10709674B2","cleaned_patent_number":"10709674","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2020-07-14","legal_status":"Granted"} US10709674B2 14 Jul, 2020 Granted 17 Jun, 2035
{"application_id":"76248","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10849860B2","cleaned_patent_number":"10849860","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2020-12-01","legal_status":"Granted"} US10849860B2 01 Dec, 2020 Granted 17 Jun, 2035
{"application_id":"76217","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"0afe638b6a7e43f6a3fe","publication_number":"US11701330B2","cleaned_patent_number":"11701330","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2023-07-18","legal_status":"Granted"} US11701330B2 18 Jul, 2023 Granted 17 Jun, 2035
{"application_id":"115999","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"0afe638b6a7e43f6a3fe","publication_number":"US11766411B2","cleaned_patent_number":"11766411","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2023-09-26","legal_status":"Granted"} US11766411B2 26 Sep, 2023 Granted 17 Jun, 2035
{"application_id":"116000","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"0afe638b6a7e43f6a3fe","publication_number":"US11963937B2","cleaned_patent_number":"11963937","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2024-04-23","legal_status":"Granted"} US11963937B2 23 Apr, 2024 Granted 17 Jun, 2035
{"application_id":"130708","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"","publication_number":"US12064399B2","cleaned_patent_number":"12064399","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2024-08-20","legal_status":"Granted"} US12064399B2 20 Aug, 2024 Granted 17 Jun, 2035
{"application_id":"76208","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US9949937B2","cleaned_patent_number":"9949937","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-04-24","legal_status":"Granted"} US9949937B2 24 Apr, 2018 Granted 17 Jun, 2035
{"application_id":"76209","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US9956183B2","cleaned_patent_number":"9956183","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-05-01","legal_status":"Granted"} US9956183B2 01 May, 2018 Granted 17 Jun, 2035
{"application_id":"76210","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US9956184B2","cleaned_patent_number":"9956184","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-05-01","legal_status":"Granted"} US9956184B2 01 May, 2018 Granted 17 Jun, 2035
{"application_id":"76211","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US9956185B2","cleaned_patent_number":"9956185","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-05-01","legal_status":"Granted"} US9956185B2 01 May, 2018 Granted 17 Jun, 2035
{"application_id":"76221","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10092525B2","cleaned_patent_number":"10092525","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2018-10-09","legal_status":"Granted"} US10092525B2 09 Oct, 2018 Granted 17 Jun, 2035
{"application_id":"76249","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US10966939B2","cleaned_patent_number":"10966939","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2021-04-06","legal_status":"Granted"} US10966939B2 Formulation 06 Apr, 2021 Granted 17 Jun, 2035
{"application_id":"76213","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US11154516B2","cleaned_patent_number":"11154516","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2021-10-26","legal_status":"Granted"} US11154516B2 26 Oct, 2021 Granted 17 Jun, 2035
{"application_id":"76214","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"6a5770bacded4587841a","publication_number":"US11311498B2","cleaned_patent_number":"11311498","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2022-04-26","legal_status":"Granted"} US11311498B2 26 Apr, 2022 Granted 17 Jun, 2035
{"application_id":"76280","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"b82c1e1eb00840fb8fd3","publication_number":"US11357741B2","cleaned_patent_number":"11357741","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2022-06-14","legal_status":"Granted"} US11357741B2 14 Jun, 2022 Granted 17 Jun, 2035
{"application_id":"76252","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US11446258B2","cleaned_patent_number":"11446258","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2022-09-20","legal_status":"Granted"} US11446258B2 20 Sep, 2022 Granted 17 Jun, 2035
{"application_id":"115989","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US11633369B2","cleaned_patent_number":"11633369","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-06-17","publication_date":"2023-04-25","legal_status":"Granted"} US11633369B2 Formulation 25 Apr, 2023 Granted 17 Jun, 2035
{"application_id":"76307","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"10fccaf0773d4ab3906b","publication_number":"US10918608B2","cleaned_patent_number":"10918608","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-13","publication_date":"2021-02-16","legal_status":"Granted"} US10918608B2 16 Feb, 2021 Granted 13 Oct, 2035
{"application_id":"76250","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"11519847ea0b404490b1","publication_number":"US11096905B2","cleaned_patent_number":"11096905","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-13","publication_date":"2021-08-24","legal_status":"Granted"} US11096905B2 Molecular Formulation 24 Aug, 2021 Granted 13 Oct, 2035
{"application_id":"76328","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"10fccaf0773d4ab3906b","publication_number":"US11400055B2","cleaned_patent_number":"11400055","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-13","publication_date":"2022-08-02","legal_status":"Patented case"} US11400055B2 02 Aug, 2022 Patented case 13 Oct, 2035
{"application_id":"76327","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"10fccaf0773d4ab3906b","publication_number":"US11065209B2","cleaned_patent_number":"11065209","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-13","publication_date":"2021-07-20","legal_status":"Granted"} US11065209B2 20 Jul, 2021 Granted 13 Oct, 2035
{"application_id":"76254","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"59a4ee58a2cc4086874f","publication_number":"US11207292B2","cleaned_patent_number":"11207292","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-26","publication_date":"2021-12-28","legal_status":"Granted"} US11207292B2 Molecular 28 Dec, 2021 Granted 26 Apr, 2039
{"application_id":"76267","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"59a4ee58a2cc4086874f","publication_number":"US11865102B2","cleaned_patent_number":"11865102","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-26","publication_date":"2024-01-09","legal_status":"Granted"} US11865102B2 Molecular Formulation 09 Jan, 2024 Granted 26 Apr, 2039
{"application_id":"138497","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"","publication_number":"US12102619B2","cleaned_patent_number":"12102619","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-03-01","publication_date":"2024-10-01","legal_status":"Granted"} US12102619B2 01 Oct, 2024 Granted 01 Mar, 2041
{"application_id":"76286","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"1cd7588451604154839f","publication_number":"US11406623B2","cleaned_patent_number":"11406623","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-03-01","publication_date":"2022-08-09","legal_status":"Granted"} US11406623B2 09 Aug, 2022 Granted 01 Mar, 2041
{"application_id":"76282","ingredient":"CANNABIDIOL","trade_name":"EPIDIOLEX","family_id":"1cd7588451604154839f","publication_number":"US11160795B2","cleaned_patent_number":"11160795","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-03-01","publication_date":"2021-11-02","legal_status":"Granted"} US11160795B2 02 Nov, 2021 Granted 01 Mar, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Cannabidiol

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.